Bronchiectasis Clinical Trial
Official title:
Flutter Valve Improves Respiratory Mechanics and Sputum Production in Bronchiectasis Patients
Considering that respiratory physiotherapy lack scientific evidence to support its application in the treatment of several obstructive diseases, this investigation was designed to evaluate the hypothesis that Flutter Valve can improve the airway clearance of hypersecretive bronchiectasis patients.
The application of airway clearance techniques is considered an important component in the
treatment of bronchiectasis patients (Van der Shans, 1997). For this purpose, a number of
techniques has been introduced in the last decades. The Flutter Valve was initially proposed
for the treatment of children with cystic fibrosis (CF) (Lindemann, 1992), but there is not
enough evidence about its utilization in patients with bronchiectasis (Van der Shans & cols,
1999).
The effects of the Flutter Valve on respiratory mechanics of patients with bronchiectasis
have been evaluated by forced spirometry (Pryor e cols, 1994; Gondor e cols, 1999; Thompson
e cols, 2002). This approach however, does not allow the characterization of mucus
transportation along the airways (Williams, 1994). The forced oscillation technique (FOT), a
non-invasive alternative to characterize respiratory mechanics, allows the evaluation of
respiratory mechanics at different frequencies without special maneuvers (Dubois e cols.,
1956). According to eligibility criteria and in a randomized order, the patients were
submitted to two protocols (control and Flutter Valve intervention), with one-week interval
between them (washout). Respiratory mechanics and expectorated sputum volume were assessed
before and after each intervention, in order to assess the Flutter Valve effect on
tracheobronchial sputum removal.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05034900 -
Does Addition of Oscillatory Positive Expiratory Pressure (OPEP) Device to a Chest Physiotherapy Program Provide Further Health Benefits in Children With Bronchiectasis?
|
N/A | |
Recruiting |
NCT04101448 -
Prevalence of Bronchiectasis in COPD Patients
|
||
Withdrawn |
NCT03376204 -
Pain Mechanisms in Patients With Bronchiectasis
|
||
Completed |
NCT02550821 -
Comparison of Physical Activity Level Between Patients With Bronchiectasis and Healthy Subjects
|
||
Completed |
NCT02656992 -
Effects of High Intensity Inspiratory Muscle Training on Exercise Capacity in Patients With Bronchiectasis
|
N/A | |
Completed |
NCT01615484 -
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
|
N/A | |
Completed |
NCT02282202 -
Evaluation of Oscillatory Positive Expiratory Pressure (oPEP) in Bronchiectasis and COPD
|
N/A | |
Completed |
NCT02048397 -
Pulmonary Rehabilitation Program (PRP) Versus PRP Plus Nutritional Supplementation in Patients With Bronchiectasis
|
N/A | |
Recruiting |
NCT01761214 -
Bacteriology and Inflammation in Bronchiectasis
|
N/A | |
Recruiting |
NCT02527486 -
Seoul National University Airway Registry
|
N/A | |
Completed |
NCT01578681 -
ELTGOL and Bronchiectasis. Respiratory Therapy
|
N/A | |
Completed |
NCT01854788 -
3 Airway Clearance Techniques in Non Cystic Fibrosis Bronchiectasis
|
N/A | |
Completed |
NCT00769119 -
A Phase II , Placebo-controlled Study to Assess Efficacy of 28 Day Oral AZD9668 in Patients With Bronchiectasis
|
Phase 2 | |
Terminated |
NCT00524095 -
Bronchiectasis in Chronic Obstructive Pulmonary Disease (COPD) Patients: Role of Prophylaxis
|
Phase 2 | |
Completed |
NCT01117493 -
Expert Patient Self-management Programme Versus Usual Care in Bronchiectasis
|
N/A | |
Recruiting |
NCT00129350 -
Assessment of Heart and Heart-Lung Transplant Patient Outcomes Following Pulmonary Rehabilitation
|
Phase 1 | |
Completed |
NCT04081740 -
Biological Determinants of Sputum Rheology in Chronic Airway Diseases
|
||
Enrolling by invitation |
NCT02546297 -
Comparisons of Inhaled LAMA or LAMA+LABA or ICS+LABA for COPD With Bronchiectasis
|
Phase 4 | |
Completed |
NCT03628456 -
Effect of HFCWO Vests on Spirometry Measurements
|
N/A | |
Completed |
NCT03750734 -
Target Validation and Discovery in Idiopathic Bronchiectasis
|